Case File
efta-efta00914878DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00914878
Pages
2
Persons
0
Integrity
No Hash Available
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: David Grosof
Subject: Re: Benoit Mandelbrot
Date: Sat, 02 Jul 2011 10:04:39 +0000
I was the first person he called to tell his , in his words , unfortunate news. he had a few months to live , but it
would be without pain. He said he felt a great affinity to me because we were both outcasts and neither " were
afraid of heights"
On Fri, Jul 1, 2011 at 9:29 PM, David Grosof
> wrote:
I was talking today with Mouad Lamani, perhaps the last man to have met collegially with Benoit Mandelbrot.
Monad is a scientist who runs R&D at Menicon, a Japanese contact lens et al. company with whom OptiOpia
enjoys a good R&D collaboration, and Mouad is also the new dean of ISMANS, an elite French engineering
school in Le Mans, France.
Thanks in part to Monad's deanly efforts, there will be two endowed professorships to honor Benoit -- one at
Yale and one at ISMANS (whose previous dean was an early, passionate 'disciple' and friend of Mandelbrot). I
was wondering whether you might have suggestions for ISMANS (1) about whom to put on the selection
committee for the first Mandelbrot Chair -- and this is at an engineering school (think: the petite MIT, with a
special connection to automotive engineering and a future in biomaterials) and (2) about whom to select for
the chair itself. Mandelbrot had such an unusual ambit of interests in pure and applied math, finance,
visualization, and more -- I thought you might have good ideas -- and good intellectual taste -- to contribute to
the selection process.
Whaddya say?
Best,
David
PS I'm all ears for stories about Benoit. I heard him give a seminar talk once, and of course struggled to digest
Fractal Geometry of Nature. But I first learned about him in academic papers on stock prices I read while
doing the options portfolio simulation modelling work at age 15 at Polytechnic Institute of NY work that was
guided by my brother's former physics teacher :-) .
David Grosof
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
EFTA00914878
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00914879
Technical Artifacts (2)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.